Suppr超能文献

妇科肿瘤医生可及性对卵巢癌死亡率的影响

The Effect of Gynecologic Oncologist Availability on Ovarian Cancer Mortality.

作者信息

Stewart Sherri L, Cooney Darryl, Hirsch Shawn, Westervelt Lauren, Richards Thomas B, Rim Sun Hee, Thomas Cheryll C

机构信息

Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, 30341, USA.

SciMetrika, LLC, Research Triangle Park, North Carolina, USA.

出版信息

World J Obstet Gynecol. 2014 May;3(2):71-77. doi: 10.5317/wjog.v3.i2.71. Epub 2014 May 10.

Abstract

AIM

To determine the association between the distribution of gynecologic oncologist (GO) and population-based ovarian cancer death rates.

MATERIALS AND METHODS

Data on ovarian cancer incidence and mortality in the United States (U.S.) was supplemented with U.S. census data, and analyzed in relation to practicing GOs. GO locations were geocoded to link association between county variables and GO availability. Logistic regression was used to measure areas of high and low ovarian cancer mortality, adjusting for contextual variables.

RESULTS

Practicing GOs were unevenly distributed in the United States, with the greatest numbers in metropolitan areas. Ovarian cancer incidence and death rates increased as distance to a practicing GO increased. A relatively small number (153) of counties within 24 miles of a GO had high ovarian cancer death rates compared to 577 counties located 50 or more miles away with high ovarian cancer death rates. Counties located 50 or more miles away from a GO practice had an almost 60% greater odds of high ovarian cancer mortality compared to those with closer practicing GOs (OR 1.59, 95% CI 1.18-2.15).

CONCLUSION

The distribution of GOs across the United States appears to be significantly associated with ovarian cancer mortality. Efforts that facilitate outreach of GOs to certain populations may increase geographic access. Future studies examining other factors associated with lack of GO access (e.g. insurance and other socioeconomic factors) at the individual level will assist with further defining barriers to quality ovarian cancer care in the United States.

摘要

目的

确定妇科肿瘤学家(GO)的分布与基于人群的卵巢癌死亡率之间的关联。

材料与方法

美国卵巢癌发病率和死亡率的数据辅以美国人口普查数据,并针对执业的GO进行分析。对GO的地点进行地理编码,以关联县变量与GO可及性之间的关系。使用逻辑回归来测量卵巢癌高死亡率和低死亡率地区,并对背景变量进行调整。

结果

执业的GO在美国分布不均,大都市区数量最多。卵巢癌的发病率和死亡率随着与执业GO距离的增加而上升。与50英里或更远距离且卵巢癌死亡率高的577个县相比,距离GO 24英里以内的县中,卵巢癌死亡率高的县相对较少(153个)。与距离执业GO较近的县相比,距离GO执业地点50英里或更远的县卵巢癌高死亡率的几率几乎高出60%(比值比1.59,95%置信区间1.18 - 2.15)。

结论

GO在美国的分布似乎与卵巢癌死亡率显著相关。促进GO与特定人群接触的努力可能会增加地理可及性。未来在个体层面研究与无法获得GO服务相关的其他因素(如保险和其他社会经济因素)的研究,将有助于进一步明确美国优质卵巢癌护理的障碍。

相似文献

1
The Effect of Gynecologic Oncologist Availability on Ovarian Cancer Mortality.
World J Obstet Gynecol. 2014 May;3(2):71-77. doi: 10.5317/wjog.v3.i2.71. Epub 2014 May 10.
2
A look at the gynecologic oncologist workforce - Are we meeting patient demand?
Gynecol Oncol. 2021 Nov;163(2):229-236. doi: 10.1016/j.ygyno.2021.08.013. Epub 2021 Aug 27.
3
Geographic disparities in the distribution of the U.S. gynecologic oncology workforce: A Society of Gynecologic Oncology study.
Gynecol Oncol Rep. 2017 Nov 15;22:100-104. doi: 10.1016/j.gore.2017.11.006. eCollection 2017 Nov.
4
Geographic and racial disparities in the quality of surgical care among patients with nonmetastatic uterine cancer.
Am J Obstet Gynecol. 2025 Mar;232(3):308.e1-308.e15. doi: 10.1016/j.ajog.2024.09.002. Epub 2024 Sep 7.
5
Gynecologic oncologist impact on adjuvant chemotherapy care for stage II-IV ovarian cancer patients.
Gynecol Oncol. 2022 Jan;164(1):3-11. doi: 10.1016/j.ygyno.2021.11.001. Epub 2021 Nov 12.
6
Potential Strategies to Increase Gynecologic Oncologist Treatment for Ovarian Cancer.
J Womens Health (Larchmt). 2021 Jun;30(6):769-781. doi: 10.1089/jwh.2021.0178.
7
Geographic Disparities in Potential Accessibility to Gynecologic Oncologists in the United States From 2001 to 2020.
Obstet Gynecol. 2023 Sep 1;142(3):688-697. doi: 10.1097/AOG.0000000000005284. Epub 2023 Aug 3.
8
Gynecologic oncologists involvement on ovarian cancer standard of care receipt and survival.
World J Obstet Gynecol. 2016;5(2):187-196. doi: 10.5317/wjog.v5.i2.187. Epub 2016 May 10.
9
Impact of care by gynecologic oncologists on primary ovarian cancer survival: A population-based study.
Gynecol Oncol. 2022 Mar;164(3):522-528. doi: 10.1016/j.ygyno.2022.01.003. Epub 2022 Jan 19.
10
Geographic access to gynecologic cancer care in the United States.
Gynecol Oncol. 2015 Jul;138(1):115-20. doi: 10.1016/j.ygyno.2015.04.025. Epub 2015 Apr 25.

引用本文的文献

1
Screening log: Challenges in community patient recruitment for gynecologic oncology clinical trials.
Contemp Clin Trials Commun. 2024 Sep 29;42:101379. doi: 10.1016/j.conctc.2024.101379. eCollection 2024 Dec.
2
Physician perspectives on clinician-to-clinician telemedical consultation for gynecologic cancers: A qualitative study.
Gynecol Oncol Rep. 2024 Mar 13;52:101363. doi: 10.1016/j.gore.2024.101363. eCollection 2024 Apr.
4
Predictors of residual disease after debulking surgery in advanced stage ovarian cancer.
Front Oncol. 2023 Jan 24;13:1090092. doi: 10.3389/fonc.2023.1090092. eCollection 2023.
6
Spatial-Temporal Trends in Ovarian Cancer Outcomes in California.
JNCI Cancer Spectr. 2022 Nov 1;6(6). doi: 10.1093/jncics/pkac067.
7
Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery.
Gynecol Oncol Rep. 2022 Oct 3;44:101075. doi: 10.1016/j.gore.2022.101075. eCollection 2022 Dec.
8
Patient and Provider Perspectives on Barriers to Accessing Gynecologic Oncologists for Ovarian Cancer Surgical Care.
Womens Health Rep (New Rochelle). 2020 Dec 28;1(1):574-583. doi: 10.1089/whr.2020.0090. eCollection 2020.
9
Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancer.
Gynecol Oncol Rep. 2022 Feb 28;40:100951. doi: 10.1016/j.gore.2022.100951. eCollection 2022 Apr.

本文引用的文献

1
The effect of provider density on lung cancer survival among blacks and whites in the United States.
J Thorac Oncol. 2013 May;8(5):549-53. doi: 10.1097/JTO.0b013e318287c24c.
3
Detection of gynecologic cancers in indigent women in an urban inner-city hospital.
Int J Gynecol Cancer. 2012 Sep;22(7):1113-7. doi: 10.1097/IGC.0b013e31825f7fa0.
4
Association of increased dermatologist density with lower melanoma mortality.
Arch Dermatol. 2012 Feb;148(2):174-8. doi: 10.1001/archdermatol.2011.345.
5
Rethinking ovarian cancer: recommendations for improving outcomes.
Nat Rev Cancer. 2011 Sep 23;11(10):719-25. doi: 10.1038/nrc3144.
6
Gynecologic oncologists and ovarian cancer treatment: avenues for improved survival.
J Womens Health (Larchmt). 2011 Sep;20(9):1257-60. doi: 10.1089/jwh.2011.3053. Epub 2011 Aug 5.
8
Surgical staging of early stage epithelial ovarian cancer: results from the CDC-NPCR ovarian patterns of care study.
Gynecol Oncol. 2011 Apr;121(1):94-9. doi: 10.1016/j.ygyno.2010.12.359. Epub 2011 Jan 21.
9
Projecting the need for gynecologic oncologists for the next 40 years.
Obstet Gynecol. 2010 Dec;116(6):1366-1372. doi: 10.1097/AOG.0b013e3181fc3a22.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验